Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Hinds

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Oncology (Williston Park, N.Y.)|May 16, 2022
Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell CarcinomaJustine Panian, Elizabeth Pan, Veronica Shi, et al.
Dermatology Online Journal|September 13, 2016
Agminated melanocytic nevus status post dabrafenib therapy for metastatic melanomaAlfredo Agulló, Brian Hinds, Raquel Santesteban, et al.
JAAD Case Reports|March 9, 2026
Small but mighty: Rhabdomyoblastic melanomaSurya A Veerabagu, Kimberly Artounian, Shelly Stepenaskie, et al.
JAAD Case Reports|March 21, 2024
Asymptomatic erythematous plaques on the trunkMadison Novice, Carrie L Vuong, Stephanie S Lee, et al.
JAAD Case Reports|April 17, 2019
Schnitzler syndrome associated with <i>MYD88</i> L265P mutationAaron M Goodman, Philip R Cohen, Alex Li, et al.
Journal of Cutaneous Pathology|October 14, 2018
Agminated blue nevus with a GNAQ mutation: A case report and review of the literatureDawn Z Eichenfield, David Cotter, John Thorson, et al.
Pediatric Dermatology|December 10, 2021
Atypical keratosis pilaris-like lesions in a patient with Bethlem myopathyStephanie S Lee, Brian Hinds, Jessica Sprague, et al.
JAAD Case Reports|September 25, 2025
Immune checkpoint inhibitor-induced toxic epidermal necrolysis responding to repeated dosing of adjuvant therapy with etanerceptLauren C LaMonica, Reid Oldenburg, Robert A Dorschner, et al.
Acta Oncologica (Stockholm, Sweden)|August 15, 2024
Radiation-associated cutaneous mastocytosis: a case report and review of the literatureAaron Trando, Karen M Austin, Brian Hinds, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic DiagnosisGrace K Sohn, Karen Keniston, Swati Kannan, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Oncology (Williston Park, N.Y.)|May 16, 2022
Leukocytoclastic Vasculitis Induced by Immune Checkpoint Inhibition in a Patient With Advanced Renal Cell CarcinomaJustine Panian, Elizabeth Pan, Veronica Shi, et al.
Dermatology Online Journal|September 13, 2016
Agminated melanocytic nevus status post dabrafenib therapy for metastatic melanomaAlfredo Agulló, Brian Hinds, Raquel Santesteban, et al.
JAAD Case Reports|March 9, 2026
Small but mighty: Rhabdomyoblastic melanomaSurya A Veerabagu, Kimberly Artounian, Shelly Stepenaskie, et al.
JAAD Case Reports|March 21, 2024
Asymptomatic erythematous plaques on the trunkMadison Novice, Carrie L Vuong, Stephanie S Lee, et al.
JAAD Case Reports|April 17, 2019
Schnitzler syndrome associated with <i>MYD88</i> L265P mutationAaron M Goodman, Philip R Cohen, Alex Li, et al.
Journal of Cutaneous Pathology|October 14, 2018
Agminated blue nevus with a GNAQ mutation: A case report and review of the literatureDawn Z Eichenfield, David Cotter, John Thorson, et al.
Pediatric Dermatology|December 10, 2021
Atypical keratosis pilaris-like lesions in a patient with Bethlem myopathyStephanie S Lee, Brian Hinds, Jessica Sprague, et al.
JAAD Case Reports|September 25, 2025
Immune checkpoint inhibitor-induced toxic epidermal necrolysis responding to repeated dosing of adjuvant therapy with etanerceptLauren C LaMonica, Reid Oldenburg, Robert A Dorschner, et al.
Acta Oncologica (Stockholm, Sweden)|August 15, 2024
Radiation-associated cutaneous mastocytosis: a case report and review of the literatureAaron Trando, Karen M Austin, Brian Hinds, et al.
Journal of Drugs in Dermatology : JDD|August 16, 2021
Characteristics of Superficial Basal Cell Carcinomas Containing More Aggressive Subtypes on Final Histopathologic DiagnosisGrace K Sohn, Karen Keniston, Swati Kannan, et al.
Pageof 5